Channing Capital Management, LLC Haemonetics Corp Transaction History

Channing Capital Management, LLC

  • $3.76 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$49.55 - $74.59 $6.25 Million - $9.4 Million
-126,075 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$57.6 - $70.59 $2.58 Million - $3.16 Million
-44,709 Reduced 26.18%
126,075 $8.9 Million
Q2 2021

Aug 16, 2021
BUY
$51.81 - $118.56 $8.85 Million - $20.2 Million
170,784 New
170,784 $11.4 Million

Others Institutions Holding HAE

# of Institutions
333
Shares Held
54M
Call Options Held
689K
Put Options Held
345K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.39B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Channing Capital Management, LLC Portfolio

Follow Channing Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Channing Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Channing Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email